Roche's Valcyte patent invalidated by Indian patent office

被引：0

|

作者：

Harrison, Charlotte

机构：

来源：

NATURE REVIEWS DRUG DISCOVERY | 2010年 / 9卷 / 06期

关键词：

D O I：

10.1038/nrd3201

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：424 / 425

页数：2

相关论文

共 50 条

[31] European patent office upholds Chiron's broad hepatitis C patent
不详
BIOTECHNOLOGY LAW REPORT, 1997, 16 (04): : 476 - 476
[32] The United States Patent & Trademark Office's Current View on Patent Eligibility
1600, Mary Ann Liebert Inc. (10): : 156 - 158
[33] The Duration of Patent Examination at the European Patent Office
Harhoff, Dietmar
Wagner, Stefan
MANAGEMENT SCIENCE, 2009, 55 (12) : 1969 - 1984
[34] Patent reform and the US Patent and Trademark Office
Rolla, JJ
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U705 - U705
[35] FOREIGN PATENT RECORDS IN THE PATENT OFFICE LIBRARY
Simpson, G. R.
Brogan, H. H.
Dryzer, F. M.
JOURNAL OF THE PATENT OFFICE SOCIETY, 1920, 2 (06): : 312 - 324
[36] European Patent Office overturns Nexium patent
不详
NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (08) : 569 - 569
[37] Genentech's patent for hGH is invalidated by US Court of Appeals for the Federal Circuit
Bisbee, C
GENETIC ENGINEERING NEWS, 1997, 17 (08): : 1 - +
[38] Indian Patent Office rejects Saxagliptin compulsory license application
Agarwal, Devika
Agarwal, Radhika
JOURNAL OF INTELLECTUAL PROPERTY LAW & PRACTICE, 2016, 11 (08) : 565 - 566
[39] All claims of the '818 patent are ... unenforceable -: Promega's Taq polymerase does not infringe Roche patent
不详
BIOTECHNOLOGY LAW REPORT, 2000, 19 (02) : 179 - 182
[40] PATENT OFFICE PROGRAMS
FLEISCHMANN, I
LIBRARY JOURNAL, 1967, 92 (01) : 32 - 33

← 1 2 3 4 5 →